WPRIM Management System> DCMS> Acta Pharmaceutica Sinica> 2008> 43> 11

Volume: 43 Issue: 11

1. Effects of in vitro conditions on release behavior of different types of sustained and controlled release formulations of breviscapin. Page:1161—1164
2. Expression, purification and antibody preparation of recombinat SARS-CoV X5 protein. Page:1157—1160
3. In vitro release study, in vivo evaluation of biodistribution and antitumor activity of HPMA copolymer-5-fluorouracil conjugates. Page:1152—1156
4. Study on in vitro release empirical method and the release mechanism of budesonide colonic localization tablet. Page:1147—1151
5. Application of the theories of materiomic release kinetics to the evaluation of the sustained release kinetics and synchronicity of yinqiaojiedu honeyed pills. Page:1140—1146
6. Preparation and properties of folate receptor-targeted cationic liposomes. Page:1134—1139
7. Effects of ligustrazine on extracellular acetylcholine levels in rat brain dialysate. Page:1128—1133
8. Pharmacokinetic studies of tetrahydropalmatine and dehydrocorydaline in rat after oral administration of yanhusuo extraction by LC-MS/MS method. Page:1123—1127
9. 2-Arylbenzofuran derivatives from Morus wittiorum. Page:1119—1122
10. Chemical constituents from the mycelia of Alternaria sp. YD-01. Page:1116—1118
11. Synthesis and antitumor activity of C3 heterocyclic-substituted fluoroquinolone derivatives (I): ciprofloxacin aminothiodiazole Schiff-bases. Page:1112—1115
12. A preliminary study on the mechanism of impaired beta cell function in monosodium glutamate obese rat with insulin resistance. Page:1106—1111
13. Rhein lysinate induces apoptosis in breast cancer SK-Br-3 cells by inhibiting HER-2 signal pathway. Page:1099—1105
14. Effects of beta-lactam antibiotics on development of tolerance and dependence to morphine. Page:1094—1098
15. Advances in the chemical and biological studies of polyamides. Page:1089—1093
16. Advances in the study of the microbial efflux pumps and its inhibitors development. Page:1082—1088
17. Advance in the research and discovery of novel drugs based on chemogenomics. Page:1077—1081
18. Advances in the study of excipient inhibitors of intestinal P-glycoprotein. Page:1071—1076